RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Conditions

• Rectal Cancer

Interventions

• OTHER: Laboratory test
• OTHER: Medical history and physical examination
• OTHER: BW and height
• OTHER: Performance status
• OTHER: Creatinine clearance
• OTHER: Biomarker
• RADIATION: Contrasting CT
• OTHER: Adverse event
• OTHER: HBs antigen and HCV antibody
• OTHER: Endoscopy
• OTHER: HBs antibody and HBc antibody
• DRUG: S-1
• DRUG: L-OHP (130mg/m2)
• DRUG: L-OHP (85 mg/m2)
• DRUG: l-LV
• DRUG: 5-FU

Sponsor

Clinical Research Support Center Kyush